Radiotherapy combined with TKI and Anti-PD-1 Antibody
RTI
Unknown other active
Quick answer
Radiotherapy combined with TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma is a Unknown program (other) at Jian Li with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jian Li
- Indication
- Stage IIIA Hepatocellular Carcinoma
- Phase
- Unknown
- Modality
- other
- Status
- active